The Use of Cost Effectiveness Analyses by PharmaceuticalBenefit Managers
Year of publication: |
1995
|
---|---|
Authors: | Grabowski, Henry G. ; Mullins, C. Daniel |
Institutions: | Duke University, Department of Economics |
Series: | |
---|---|
Type of publication: | Book / Working Paper |
Notes: | Published under the title "Pharmacy Benefit Management, Cost-Effectiveness Analysis and Drug Formulary Decisions," in SOCIAL SCIENCE AND MEDICINE, Vol. 45, 1997, pages 535-544 Number 95-50 |
Classification: | D61 - Allocative Efficiency; Cost-Benefit Analysis ; I11 - Analysis of Health Care Markets |
Source: |
-
Janoska, Wilfried, (2012)
-
Analysing Shared Service Contracts: The Case of Food Services for Winnipeg Hospitals
Cyrenne, Philippe, (1999)
-
Herwartz, Helmut, (2011)
- More ...
-
Special issue: Pharmaceutical economics : essays in honor of Henry G. Grabowski
Mullins, C. Daniel, (2011)
-
R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry
Dimasi, Joseph A., (1995)
-
Longer Patents for Increased Generic Competition:The Waxman-Hatch Act after One Decade
Grabowski, Henry G., (1995)
- More ...